FindTrial
Sign In

Study the effects of Unani treatment on Hypertension

A Clinical study On The management of Essential hypertension grade-II with Combination Therapy of two Unani polyherbal formulation-A Randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057350
Enrollment
40
Registered
2023-09-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Extract of ASROL ( Rauwolfia serpertina)25mg , ASGANDH ( Withania somnifera)150mg , SHANKPUSHPI (Evolvulus alsinoides),175mg PARSIOSHA (Adiantum capillus veneris)150mg, FILFIL SIYAH (Pi

Sponsors

Ayurvedic and Unani tibbia college hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagonsed cases of essential hypertension grade-II, Patient willing to participate and sign the consent form

Exclusion criteria

Exclusion criteria: secondary hypertension, patients with sign of end organ (target organ )damage, pateints taking oral contraceptive pills, long term use of steriods and the drugs which increase the blood pressure, pregnant and lactating women,Renal &hepatic insufficency and malignancy , patients unwilling to sign the consent form

Design outcomes

Primary

MeasureTime frame
To develop a safe, efficacious & economical treatment for essential hypertension Grade-2Timepoint: Baseline, 8th day, 15th day, 22nd day and 30th day—

Secondary

MeasureTime frame
Expected Blood pressure target to achieve around 120/80 mmHg during mental And physical restTimepoint: 8th Day 15th Day 22nd Day 30th Day—

Countries

India

Contacts

Public ContactKhan Iram Mohd Tayyab

Ayurvedic and Unani tibbia college

drkhannaseem.akhtarkhan@gmail.com9810815997

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026